C alcific aortic stenosis is the most common form of valvular heart disease in the Western world and represents a major healthcare burden that is projected to increase with an aging population. 1 However, the underlying pathophysiology remains incompletely defined, and there are currently no effective medical treatments capable of altering its course. 2 Unfortunately, histological studies are limited by the availability of valve tissue from patients with advanced disease and do not lend themselves to the longitudinal study of disease progression. Alternative techniques are therefore required to investigate the pathogenesis and progression of this condition.
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Positron emission tomography (PET) combined with computed tomography (CT) is a noninvasive imaging technique that allows the identification and quantification of specific biochemical processes within small anatomic structures, such as the aortic valve. Furthermore, 2 common PET tracers target calcification and inflammation, which are believed to play a key role in the development of the disease. PET/CT therefore holds considerable promise as a means of investigating the pathophysiology of aortic stenosis.
18F-Flurodeoxyglucose (18F-FDG) is a glucose analogue that is taken up into cells by glucose transport proteins and enters the glycolytic metabolic pathway. After the initial hexokinase step, 18F-FDG-6-phosphate cannot be metabolized further and becomes trapped within cells that have high metabolic requirements, such as macrophages. PET imaging with the use of 18F-FDG has become an established means of quantifying vascular inflammation in both the aorta and carotid arteries, 3, 4 correlating with plaque macrophage burden 5 and symptomatic status. 4 18F-Sodium fluoride (18F-NaF) is an alternative PET tracer that is directly incorporated into exposed bone crystal (hydroxyapatite) via an exchange mechanism with hydroxyl groups. 6 It is therefore thought to detect areas of novel calcification and regions of calcium remodeling and is used clinically for the detection of primary osteoblastic tumors and bone metastases. 7 More recently, studies have described 18F-NaF uptake as a marker of calcification within atherosclerotic plaque 8, 9 ; however, to date this tracer has not been used to study patients with aortic stenosis.
In this PET study, we investigated 18F-NaF and 18F-FDG uptake in the valves of patients with aortic stenosis with 3 major aims: to examine the feasibility of this approach, to establish its repeatability, and to assess the relative importance of inflammation and calcification at different stages of the disease.
Methods
Consecutive patients aged Ͼ50 years with aortic sclerosis and mild, moderate, and severe aortic stenosis attending the outpatient department of the Royal Infirmary of Edinburgh were considered for participation in this study. Exclusion criteria included insulindependent diabetes mellitus, blood glucose Ͼ200 mg/dL, and inability to undergo PET/CT scanning. Patients were not approached if they fulfilled any of the exclusion criteria or if their clinician believed that participation was not appropriate. Of the patients approached, 52% agreed to take part in the trial. These patients were then compared with age-and sex-matched control subjects with a normal aortic valve and a similar range of comorbidity. The study was conducted with local research ethics committee approval and the written informed consent of all patients.
Echocardiography
Valve disease severity was assessed by a single dedicated research ultrasonographer on a dedicated machine (Phillips Medical Systems, Best, Netherlands) under standardized conditions and according to a formal protocol. 10, 11 Patients were studied with the use of an S51 pure wave transducer (Phillips Medical Systems) for 2-dimensional, M-mode, and pulsed and continuous wave Doppler studies. Continuous wave Doppler velocities were confirmed with the use of a D2 CWC transducer (Phillips Medical Systems) from the apex, right sternal edge, and suprasternal notch. Measurements were determined online and averaged from 3 cardiac cycles or 5 if the patient was in atrial fibrillation.
Aortic sclerosis was defined as a thickened aortic valve on echocardiography in the absence of accelerated flow though the valve (peak jet velocity Ͻ2 m/s). The severity of aortic stenosis was graded according to American Heart Association and American College of Cardiology criteria with the use of peak transvalvular aortic valve velocity and mean and maximum aortic valve pressure gradients. 12 In our clinical laboratory, we previously demonstrated a coefficient of reproducibility of 0.32 m/s for the Doppler measurement of peak aortic valve velocity in patients with aortic stenosis. 10 Aortic stenosis severity was also assessed with the use of the time velocity integral, the dimensionless index, and the aortic valve area, calculated with the continuity equation.
PET and CT
Combined PET/CT scans of the aortic valve were performed on 2 occasions in close succession with the use of a hybrid scanner (Biograph mCT, Siemens Medical Systems, Erlangen, Germany). On the first occasion, a target dose of 125 MBq 18F-NaF was injected intravenously, and patients rested in a quiet environment for the 60-minute uptake period. An attenuation-correction CT scan (nonenhanced, low dose 120 kV, 50 mAs) was then performed, followed by PET imaging covering 2 bed positions centered over the valve in 3-dimensional mode for 10 minutes. On the second occasion, a target dose of 200 MBq 18F-FDG was injected, and patients rested in a quiet environment for 90 minutes. Combined PET/CT imaging was then performed as described for the 18F-NaF scan but with the use of a 15-minute bed time. Tracer circulation times were based on previous studies with the use of 18F-FDG and 18F-NaF in atherosclerosis 4, 8, 9 and aimed to allow for optimal contrast between the aortic wall, aortic valve, and blood pool. An ECG-gated breath-hold CT scan (nonenhanced, 40 mAs per rotation [CareDose], 100 kV) was performed of the aortic valve immediately after the 18F-NaF PET/CT scan for calculation of the aortic valve calcium score.
The PET data were reconstructed with the use of the Siemens Ultra-HD (time of flightϩTrue X) reconstruction algorithm. Corrections were applied for attenuation, dead time, scatter, and random coincidences. All image analysis was performed on fused PET/CT data sets.
Dietary Restrictions
Intense uptake of 18F-FDG by the left ventricle leads to difficulties in discriminating between activity in the aortic valve and the myocardium. All patients in our cohort were asked to observe a carbohydrate-free diet for 24 hours before their 18F-FDG scan because this suppresses myocardial uptake as the heart switches from glucose to free fatty acid metabolism. [13] [14] [15] Patients were provided with a list of food and drink to avoid and reminded of these restrictions the day before their scan. Dietary diaries were recorded, and patients were categorized into dietary compliance or noncompliance. Myocardial tracer uptake was assessed by recording the maximum standardized uptake value (SUV) in the left ventricular septal myocardium. The SUV is the decay-corrected tissue uptake divided by the injected dose per body weight and is a semiquantitative dimensionless unit that is a widely used and validated measure of tissue 18F-FDG and 18F-NaF uptake. 4, 8, 16 High myocardial 18F-FDG uptake was prespecified as an SUV value Ն5.0, whereas low uptake, indicating successful myocardial suppression, was defined by measurements Ͻ5.0. 13
Quantification of Tracer Uptake in the Aortic Valve
PET image quantification is usually performed in the axial, coronal, or sagittal planes. However, the aortic valve is a complex 3-dimensional structure that does not align perfectly with any of these orthogonal planes, making accurate identification of the boundaries of the valve difficult with the use of standard techniques. To try to overcome this, the PET and CT images were fused and analyzed with the use of a workstation (OsiriX version 3.5.1 64-bit; OsiriX Imaging Software, Geneva, Switzerland) that allows for rotation of the plane of view into the true axis of the valve. This facilitated the more accurate delineation of regions of interest around the valve, as described below.
18F-NaF: Short-Axis Method
The fused PET/CT image was rotated in a 3-dimensional multiplanar reconstruction mode to provide a coaxial short-axis view of the aortic valve ( Figure 1 ). Starting superiorly, we drew a circular region of interest around the aortic valve on 3-mm slices guided by anatomic information provided by CT and any obvious valvular calcification ( Figure 1C ). Further regions of interest were drawn on adjacent slices until the whole valve had been examined. Mean and maximum SUVs were calculated for each slice and then for the valve as a whole after these values were averaged. However, SUV measurements in vascular structures are influenced by variation in 18F-FDG and 18F-NaF activity in the blood pool. Therefore, SUV measurements were divided by an averaged mean SUV value derived from 5 circular regions of interest drawn in the central blood pool of the superior vena cava. This provided mean and maximum tissue-tobackground ratios (TBRs). 5, 17 
18F-FDG Analysis
The coaxial short-axis method was performed for 18F-FDG as described above. Whereas the prescan dietary restrictions sought to minimize the difficulties cause by myocardial 18F-FDG uptake, we also explored 2 additional image analysis approaches to define better and to assess more specifically the valvular uptake ( Figure 1 ). In the long-axis technique, images were reoriented into a modified coronal view, from which it was hoped the boundaries of myocardial uptake would be more clearly observed and therefore avoided. In the center valve technique, regions of interest were again drawn on the coaxial short-axis view but in the center of the valve, thereby excluding the base of the valve leaflets and any potential incorporation of myocardial or aortic wall uptake. 18 For all techniques, measurements were taken on adjacent 3-mm slices, and mean and maximum SUV and TBR values were calculated for the valve.
Repeatability Studies
Twenty-five patients with a range of aortic valve disease were selected at random from the cohort. After establishment of the aortic valve image analysis methodology, all scans from these patients were analyzed independently by 2 trained observers (M.R.D., C.J.). For each technique, this provided measures of interobserver repeat- Note the intense 18F-NaF uptake (white, red, and yellow areas) in the calcified aortic valve as well as in the ribs, clavicles, and arch of the aorta. The purple axis has been rotated so that it lies perpendicular to the aorta and parallel to the aortic valve. B, Modified sagittal view of the valve (yellow axis). The purple axis has again been rotated so that it lies perpendicular to the aorta and parallel to the aortic valve. C, A coaxial short-axis view of the aortic valve is now obtained along the purple axis. White areas denote areas of existing calcium, and yellow/red regions denote areas of increased 18F-NaF uptake. A region of interest has been drawn around the valve (white line). 18F-FDG: D, Shortaxis technique. The imaging plane has been reoriented as described for 18F-NaF to provide the coaxial short-axis view shown. This patient has intense myocardial 18F-FDG uptake, which appears to spill into the aortic valve (white arrows) and makes appreciation of the less intense activity in the valve difficult. In the short-axis technique, the green region of interest has been drawn to include as much of the valve as possible while avoiding the myocardial activity. E, Long-axis technique. A region of interest has been drawn on the modified coronal images, attempting to avoid the myocardial uptake. F, Center valve technique. In the same patient, the region of interest has been drawn in the center of the valve well away from myocardial uptake around the periphery. Purple borders indicate images taken in the coaxial short-axis view of the valve. Blue borders indicate images taken in the modified coronal view. Yellow borders indicate images taken in the modified sagittal view of the valve.
ability for mean and maximum SUV and TBR values. To assess intraobserver variation, both observers repeated the analyses at least 2 weeks later to minimize recall bias.
Statistical Methods
Continuous variables were expressed as meanϮSD and compared with the unpaired Student t test or 1-way ANOVA when appropriate. All continuous variables were tested for normal distribution with the Shapiro-Wilk test. In cases in which data were not normally distributed, they were presented as the medianϮinterquartile range. Categorical variables were expressed as percentages and analyzed with the 2 test. Correlations between normally distributed data were performed with Pearson correlation and presented as r 2 values. Spearman correlation was used for nonparametric data. The 95% normal range for differences between sets of SUV and TBR measurements (the limits of agreement) were estimated by multiplying the SD of the mean of the differences by 1.96. 19 Intraclass correlation coefficients with 95% confidence intervals were calculated for intraobserver and interobserver variation. Statistical analysis was performed with the use of SPSS version 18 (SPSS Inc, Chicago, IL). A 2-sided PϽ0.05 was regarded as statistically significant.
Results

Patient Population
A total of 121 patients were recruited (aged 72Ϯ8 years; 69% male; peak aortic valve velocity 2.8Ϯ1.2 m/s) and had both 18F-NaF (66Ϯ7 minutes after 124Ϯ10 MBq) and 18F-FDG (94Ϯ7 minutes after 197Ϯ14 MBq) scans of their aortic valve Ͻ1 month apart. This cohort comprised 20 control subjects, 20 patients with aortic sclerosis, and 25 patients with mild, 33 with moderate, and 23 with severe aortic stenosis. Patients were well matched for age, sex, and comorbidity (Table 1) .
Dietary Restrictions and Blood Pool Uptake
Average myocardial SUV across the entire cohort was 4.6Ϯ3.6, and dietary restrictions effectively suppressed 18F-FDG myocardial uptake (SUV Ͻ5) in 67% of patients, similar to that observed in previous studies. 20 On the basis of dietary diaries, 61% of patients complied with the dietary 
Repeatability Studies
18F-Sodium Fluoride
Among the 25 patients selected (aged 74Ϯ10 years; 64% male; aortic valve peak velocity 3.8Ϯ1.1 m/s), aortic valve 18F-NaF uptake showed excellent interobserver repeatability for the mean and maximum SUV and TBR values. There were no fixed or proportional biases, and the majority of data fell within narrow limits of agreement: Ϯ0.20 for mean and Ϯ0.21 for maximum TBR measurements (Table 2 and Figure  2 ). Limits of agreement for intraobserver measurements were similarly good, and intraclass coefficients for interobserver and intraobserver repeatability were all Ͼ0.95, indicating excellent agreement (Table 3) .
18F-Fluorodeoxyglucose
Avoiding myocardial uptake was difficult with the use of the short-and long-axis techniques, particularly for the latter.
Reproducibility statistics reflected this and demonstrated that the variability was much greater than for 18F-NaF. The interobserver limits of agreement for the short-axis technique were Ϯ0.28 and Ϯ0.72 for the mean and maximum TBR values, respectively, and were Ϯ0.78 and Ϯ1.18 with the long-axis approach (Table 2 and Figure 2 ). The intraclass coefficients for the short-axis technique were 0.76 and 0.59 for the mean and maximum TBR values, respectively, and were 0.39 and 0.52 with the long-axis approach (Table  3) . Intraobserver repeatability measures were similarly poor. The center valve analysis was more reproducible. There were no fixed or proportional biases in the differences between interobserver measurements, and the data fell within narrow limits of agreement: Ϯ0.11 for mean and Ϯ0.13 for maximum TBR values (Table 2 and Figure 2 ). Intraobserver repeatability was similarly good, and intraclass coefficients were all Ͼ0.90, indicating excellent agreement (Tables 2 and 3 ).
There were concerns that the center valve technique might underestimate 18F-FDG activity in the valve by excluding the valve ring. However, there was no difference between mean uptake values calculated by the center valve technique and the short-axis method (center valve TBR: 1.43Ϯ0.17; short Mean difference between standard uptake value (SUV) and tissue-to-background ratio (TBR) measurements for 18F-sodium fluoride (18F-NaF) valve uptake with the use of the short-axis technique and 18F-fluorodeoxyglucose (18F-FDG) uptake with the use of the short-axis, center valve, and long-axis techniques is shown (95% confidence intervals in parentheses). The short-axis technique for 18F-NaF and the center valve technique for 18F-FDG display no fixed proportional bias with narrow limits of agreement.
axis: 1.47Ϯ0.45; Pϭ0.473). Maximum TBR values were lower with the use of the former approach (center valve: 1.60Ϯ0.20; short axis: 1.80Ϯ0.45; Pϭ0.041). However, this difference was no longer apparent when patients with high myocardial uptake (nϭ11) were excluded from the analysis (center valve: 1.56Ϯ0.18; short axis: 1.64Ϯ0.20; Pϭ0.245), reflecting the wide limits of agreement (Ϯ1.05) for the short-axis technique when myocardial suppression was poor. By contrast, limits of agreement for the center valve technique were equally good in patients with low and high myocardial uptake (Ϯ0.13 versus Ϯ0.14, respectively; Pϭ0.919). Given this and other advantages, subsequent analysis of the entire cohort was performed with the center valve method for 18F-FDG.
Aortic Valve Uptake
18F-Sodium Fluoride
Focal 18F-NaF uptake was observed in the valves of patients with calcific aortic valve disease in areas overlying, adjacent to, and remote from existing calcification. Areas of established calcium were also observed frequently in the absence of increased 18F-NaF activity (Figure 3) . Compared with control subjects, valvular 18F-NaF uptake was higher in patients with both aortic sclerosis (maximum TBR: 1.55Ϯ0.17 versus 1.92Ϯ0.31; PϽ0.001) and aortic stenosis (maximum TBR: 1.55Ϯ0.17 versus 2.87Ϯ0.82; PϽ0.001). The highest maximum TBR value in the control group was 1.97, which was used to divide patients with aortic valve disease into those with increased 18F-NaF uptake (Ͼ1.97) and those without (Յ1.97). Overall, 45% of patients with aortic sclerosis and 91% of those with aortic stenosis had increased uptake. The proportion of patients with increased activity rose sharply with increasing disease severity such that 100% of patients with severe disease had increased uptake (Table 4) .
All measures of 18F-NaF uptake displayed a progressive rise with increasing aortic jet velocity (maximum TBR: r 2 ϭ0.540, PϽ0.001; Table 4 and Figure 4) 
18F-Fluorodeoxyglucose
18F-FDG showed a more diffuse pattern of activity within the valve (Figure 3 ), and compared with control subjects, uptake was increased in patients with aortic sclerosis (maximum TBR: 1.30Ϯ0.13 versus 1.47Ϯ0.15; PϽ0.001) and aortic stenosis (maximum TBR: 1.30Ϯ0.13 versus 1.58Ϯ0.21; PϽ0.001). The highest maximum TBR value in the control group was 1.63, which was used to divide patients with aortic valve disease into those with increased 18F-FDG uptake (Ͼ1.63) and those without (Յ1.63). Overall, 20% of patients with aortic sclerosis and 35% of patients with aortic stenosis had increased uptake. The proportion of patients with increased activity in the valve again rose with increasing aortic valve disease; however, this rise was more gradual than for 18F-NaF, with only 52% of patients with severe disease demonstrating increased activity (Table 4 ). All measures of 18F-FDG activity displayed a progressive rise with increasing aortic jet velocity (maximum TBR: r 2 ϭ0.218, PϽ0.001; Table 4 and Figure 4 ), the aortic valve Agatston score (r 2 ϭ0.138, PϽ0.001), and other echocardiographic measures of aortic stenosis (time-velocity integral: r 2 ϭ0.246, PϽ0.001; aortic valve area: r 2 ϭ0.184, PϽ0.001; dimensionless index: r 2 ϭ0.229, PϽ0.001). These correlations were weaker and more modest than for 18F-NaF. A modest correlation was also observed between valvular 18F-NaF and 18F-FDG activities (maximum TBR: r 2 ϭ0.174, PϽ0.001).
Discussion
In this PET study, we have established the feasibility of evaluating 18F-NaF and 18F-FDG activity in patients with aortic stenosis. Moreover, we have demonstrated excellent repeatability for the quantification of these tracers in the valve as measures of calcification and inflammation, respectively. 18F-NaF and 18F-FDG activity was increased in patients with both aortic sclerosis and stenosis, displaying a progressive rise in uptake with increasing disease severity. However, calcification rather than inflammation appears to be the predominant process affecting the valve, particularly in the latter stages of the disease, in which a more marked progression in 18F-NaF activity was observed that was disproportionate to 18F-FDG.
Valve calcification plays a key role in the development of aortic stenosis. Hydroxyapatite becomes deposited on a bonelike matrix containing collagen, osteopontin, and other bone matrix proteins [21] [22] [23] to form nodules that progress until, by the end stage of the disease, lamellar bone, microfractures, and hemopoietic tissue can all be identified. 23 This appears to occur as part of a highly regulated process, coordinated by increased osteoblast activity 24, 25 and the local production of osteopontin, osteocalcin, bone sialoproteins, and bone morphogenic protein-2, all of which are more commonly associated with skeletal bone formation. 21, 23, 25, 26 Established aortic valve calcium can be measured accurately with the use of CT, 10 but measurement of 18F-NaF uptake offers, for the first time, the possibility of detecting areas of developing calcification within the valve. In this study, 18F-NaF uptake was observed in regions adjacent to and remote from existing calcium, suggesting expansion of the calcific process to new areas of the valve. In addition, uptake was observed in regions overlapping with that of established calcium, and, in these areas, activity is likely to represent calcium remodeling and maturation of the calcific process.
18F-NaF activity was increased in the valves of patients with aortic sclerosis and stenosis compared with control subjects and demonstrated a marked progressive rise with increasing disease severity accounting for Ͼ50% of the variance associated with valve stenosis. Moreover, increased valvular 18F-NaF activity was observed in 45% of patients with aortic sclerosis, 91% of patients with aortic stenosis, and all patients with severe stenosis. Calcium accumulation is the predominant mechanism by which valve cusp rigidity increases and aortic stenosis advances. As such, this technique offers considerable promise as a biomarker of disease activity and as a means of predicting disease progression. Longitudinal studies are now required to determine whether calcification activity quantified by 18F-NaF uptake is an accurate predictor of disease progression and superior to baseline measures of valve severity and calcium scores. If confirmed, these studies would pave the way for mechanistic studies of medical interventions to interrupt progressive calcific disease with the use of 18F-NaF activity as a surrogate biomarker and end point.
In the early stages of aortic stenosis, endothelial damage secondary to mechanical stress and lipid deposition triggers an inflammatory response within the valve. This is characterized by increased macrophage 27 and T-cell activity within the valve leaflets and the expression of a range of proinflammatory cytokines including transforming growth factor-␤1, 28 tumor necrosis factor-␣, and interleukin-1␤. 29 The inflammatory response is thought to trigger the fibrotic and calcific processes that subsequently drive valve orifice narrowing. Thus, identifying and quantifying valvular inflammation with 18F-FDG have the potential to be critical in the evaluation of aortic stenosis. In the present study, 18F-FDG uptake was higher in patients with aortic sclerosis and stenosis compared with control subjects, and activity again rose with increasing valve severity. However, this association was weaker and the increase in activity was more modest than for 18F-NaF. Indeed, increased valvular 18F-FDG activity was only observed in 20% of patients with aortic sclerosis, 35% of patients with aortic stenosis, and 52% of patients with severe stenosis. Although this may reflect the high cutoff used for increased activity or an insensitivity of 18F-FDG in detecting inflammation, these data suggest that calcification is the predominant pathogenic process in aortic stenosis and a better target for novel therapeutic strategies. It might also explain the disappointing results of statin therapy in this condition, which has consistently failed to modify vascular calcification even in the coronary circulation despite reducing systemic markers of inflammation. 11,30 -32 A recent retrospective study described increased 18F-FDG uptake in the valves of 42 patients with cancer who were coincidentally found to have aortic stenosis. 18 However, in contrast to our study, a reduction in activity was observed in patients with severe compared with moderate disease. This difference is likely to reflect the small number of subjects in the severe subgroup (nϭ8), the retrospective nature of the study analysis, and the confounding effects of coexistent malignancy. In contrast, we have prospectively recruited a larger, well-defined cohort of patients with aortic stenosis who are more likely to be representative of those seen in cardiology practice. Moreover, we studied patients following dietary restrictions to minimize the effects of myocardial uptake and spillover into the valve. Our data are in agreement with a modest yet sustained and progressive increase in inflammation even in those with advanced disease.
Study Limitations
With exclusion of part of the valve, it is possible that the center valve technique employed for 18F-FDG analysis may underestimate valvular inflammation. However, there were no differences in mean uptake values compared with the short-axis technique. This reflects the diffuse nature of 18F-FDG activity in stenotic valves and the equal distribution of lesions between the base of the valve leaflets (54%) and the mid portion and tips (46%). 33 This study has not validated 18F-FDG and 18F-NaF activity against histological samples. Although the mechanism of uptake for both tracers has been investigated in other tissues, further work is required in the valve to address this issue (see the online-only Data Supplement).
Conclusion
The evaluation of aortic stenosis with the use of PET is feasible and highly reproducible, with 18F-FDG and particularly 18F-NaF holding considerable promise as novel biomarkers of disease activity. Both calcification and inflammation are increased in patients with aortic valve disease compared with control subjects, and the activity of both rises steadily with increasing disease severity. However, calcification appears to be the predominant pathological process, particularly in the latter stages of the disease, and would therefore appear to be a better target for future potential medical therapies.
